Buyer Name: NHS England
Buyer Address: Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
Contact Email: katie.noonan@nhs.net
NHS National Framework Agreement for Omalizumab
Buyer Contact Info
Status
complete
complete
Procedure
open
open
Value
87433000.0 GBP
87433000.0 GBP
Published
30 Dec 2025, 16:29
30 Dec 2025, 16:29
Deadline
n/a
n/a
Contract Start
01 Feb 2026, 00:00
01 Feb 2026, 00:00
Contract End
31 Aug 2027, 22:59
31 Aug 2027, 22:59
Category
n/a
n/a
CPV
33600000 - Pharmaceutical products
33600000 - Pharmaceutical products
Region
n/a
n/a
Awarded To
Celltrion Healthcare United Kingdom Limited, MERCURY PHARMACEUTICALS LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED
Celltrion Healthcare United Kingdom Limited, MERCURY PHARMACEUTICALS LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED
Official Source
Open Find a Tender
Open Find a Tender
Description
Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Linked Documents
Select a document to preview.
Opportunity Context
Lots
Lot 1 Status: complete
Documents
Document Description: Not published
Contracts
Contract Title: Lot 1 - CM/TNS/25/5734
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"id": "2",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-11685363",
"name": "Celltrion Healthcare United Kingdom Limited"
},
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
]
}
],
"buyer": {
"id": "GB-PPON-PDPT-3135-BWWY",
"name": "NHS England"
},
"contracts": [
{
"aboveThreshold": true,
"awardID": "2",
"dateSigned": "2025-12-12T00:00:00Z",
"documents": [
{
"description": "CONTRACT COPY Documents UK7 Contract Details Notice - CM-TNS-25-5734 Omalizumab",
"documentType": "contractSigned",
"format": "application/pdf",
"id": "A-9646",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-9646"
},
{
"datePublished": "2025-12-30T16:29:54Z",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"format": "text/html",
"id": "086501-2025",
"noticeType": "UK7",
"url": "https://www.find-tender.service.gov.uk/Notice/086501-2025"
}
],
"hasRenewal": true,
"id": "2",
"period": {
"endDate": "2027-08-31T23:59:59+01:00",
"maxExtentDate": "2029-08-31T23:59:59+01:00",
"startDate": "2026-02-01T00:00:00Z"
},
"renewal": {
"description": "Option or options to extend (at the Authority\u2019s discretion) for a period or periods up to a total of 24 months."
},
"status": "active",
"title": "Lot 1 - CM/TNS/25/5734",
"value": {
"amount": 87433000.0,
"amountGross": 104919600.0,
"currency": "GBP"
}
}
],
"date": "2025-12-30T16:29:54Z",
"id": "086501-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-058e04",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"region": "UKI45",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"contactPoint": {
"email": "katie.noonan@nhs.net"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
],
"url": "https://www.england.nhs.uk/"
},
"id": "GB-PPON-PDPT-3135-BWWY",
"identifier": {
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
},
"name": "NHS England",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"region": "UKI74",
"streetAddress": "The Charter Building"
},
"contactPoint": {
"email": "info@celltrionhc.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-11685363",
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"name": "Celltrion Healthcare United Kingdom Limited",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "EC2M 1QS",
"region": "UKI31",
"streetAddress": "Dashwood House"
},
"contactPoint": {
"email": "commercialsupporthospitals@advanzpharma.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-02619880",
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"supplier"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "W12 7FQ",
"region": "UKI33",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-COH-00119006",
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"coveredBy": [
"GPA"
],
"description": "Project title: NHS National Framework for Omalizumab commencing 1st February 2026 \nOffer reference number: CM/TNS/25/5734\nPeriod of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority\u2019s discretion) for a period or periods up to a total of 24 months. \nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value \u0026 Access, NHS England",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "C382504",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"techniques": {
"frameworkAgreement": {
"description": "Please refer to the ITO Documents for the Operation Description",
"method": "withReopeningCompetition",
"type": "closed"
},
"hasFrameworkAgreement": true
},
"title": "NHS National Framework Agreement for Omalizumab"
}
}